Fountaine Pajo (ALFPC)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 74.80 |
|---|---|
| 52-week range | 70.60 – 114.38 |
| Return, 1 month / 3 months | −7.7% / −16.0% |
| Return, 1 year / 3 years | −25.6% / −23.2% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 23.8% |
| Worst drawdown (1 year) | -33.9% |
| Average daily value traded | 0.06M EUR |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fountaine Pajot is a French boatbuilder based in La Rochelle that designs and builds cruising catamarans and sailing yachts. Its range covers motor catamarans and sailing catamarans for private owners and charter operators, and the company also builds monohull sailboats through its Dufour Yachts brand. Its customers are recreational sailors and charter businesses, and its boats are marketed through a dealer network in France and abroad.
Fountaine Pajo trades under the code ALFPC on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fountaine Pajo (ALFPC) trades on the Euronext Paris in France. It last closed at EUR 74.80 on 19 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 369 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 25.6% and over the last three months it fell 16.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.1% | ||
| From 52-week high | -32.1% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.0% | ||
| 6-month return | -22.5% | ||
| 12-month return, skipping the last month | -19.4% | ||
| Risk (lower is better) | 67 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 23.8% | ||
| Worst drawdown (1 year) | -33.9% | ||
| Liquidity | 58 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | −7.7% |
| 3 months | −16.0% |
| 6 months | −22.5% |
| 1 year | −25.6% |
| 3 years | −23.2% |
| 5 years | −34.7% |
Signals
| 50-day / 200-day average | 80.91 / 89.17 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Apr 2026 | EUR 2.5200 |
| 23 Apr 2025 | EUR 2.5200 |
| 23 Apr 2024 | EUR 2.2000 |
| 24 Apr 2023 | EUR 2.0300 |
| 27 Apr 2022 | EUR 1.8500 |
| 26 Apr 2021 | EUR 1.6800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.